Precision Business Insights has published a report on the global mrna vaccines market, estimating its value at USD 13.8 Billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 17.1% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/mrna-vaccines-market

Market Definition:          

mRNA vaccines, also known as messenger RNA vaccines, are a class of vaccination in which the body's cells are instructed to manufacture a particular protein that initiates an immune response against a specific disease, like a virus, using synthetic genetic material (mRNA).

Drivers:

1) Rising prevalence of infectious diseases.
2) Technological advancements in mRNA platforms.

The global mrna vaccines market segmentation:

1) By Indication: Infectious Diseases, Cancer, and Other Therapeutic Areas.
2) By Type: Prophylactic Vaccines and Therapeutic Vaccines.
3) By End User: Hospitals & Clinics, Research Institutions, and Others.

Regional Overview:
The report also examines the current concerns and their Future Effects on the mrna vaccines market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the mrna vaccines market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.

·         North America (U.S., Canada)

·         Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)

·         Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)

·         Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)

·         Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

The competitive landscape is dominated by major players like Moderna, Inc. (USA) BioNTech SE (Germany) Pfizer Inc. (USA) CureVac SE (Germany) GlaxoSmithKline plc (UK) Sanofi S.A. (France) AstraZeneca plc (UK/Sweden) Gennova Biopharmaceuticals Ltd. (India) Arcturus Therapeutics Holdings Inc. (USA) Translate Bio (USA – acquired by Sanofi) Boehringer Ingelheim (Germany) Daiichi Sankyo Co., Ltd. (Japan) ModernaTX, Inc. (subsidiary of Moderna) eTheRNA immunotherapies NV (Belgium) Providence Therapeutics Holdings Inc. (Canada) Ziphius Therapeutics NV (Belgium) Acuitas Therapeutics (Canada) Arcturus Therapeutics (Singapore collaboration) BioNTech Manufacturing GmbH (Germany) Beam Therapeutics Inc. (USA) Ethris GmbH (Germany) Replicate Bioscience (USA) Tiba Biotech (USA) Enesi Pharma (UK) Strand Therapeutics (USA) Cartesian Therapeutics (USA) Chimeron Bio (USA) eTheRNA Manufacturing (Belgium) Orna Therapeutics (USA) Arna Therapeutics (USA) Lonza Group AG (Switzerland) Catalent, Inc. (USA) Samsung Biologics (South Korea) Fujifilm Diosynth Biotechnologies (Japan) Thermo Fisher Scientific Inc. (USA) Wacker Chemie AG (Germany) BioNTech IMFS (Germany) Evonik Industries AG (Germany) Polymun Scientific Immunbiologische Forschung GmbH (Austria) Recipharm AB (Sweden)

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747